Keratoconjunctivitis due to Acanthamoeba
ICD-10 B60.13 is a billable code used to indicate a diagnosis of keratoconjunctivitis due to acanthamoeba.
Keratoconjunctivitis due to Acanthamoeba is a severe ocular infection caused by the Acanthamoeba species, a free-living protozoan found in various environments, including soil and freshwater. This condition primarily affects contact lens wearers, particularly those who do not adhere to proper hygiene practices. The infection can lead to significant corneal damage, resulting in pain, redness, photophobia, and blurred vision. Diagnosis is often challenging due to the nonspecific symptoms that can mimic other forms of keratitis. Diagnostic methods include corneal scraping and culture, as well as PCR testing to identify the organism. Treatment typically involves aggressive topical antimicrobial therapy, including biguanides (such as chlorhexidine) and diamidines (such as propamidine), and in severe cases, surgical intervention may be necessary. Early recognition and treatment are crucial to prevent vision loss and complications associated with this potentially devastating infection.
Detailed clinical notes on symptoms, diagnostic tests, and treatment plans.
Patients presenting with contact lens-related eye infections, particularly with corneal ulcers.
Ensure that all diagnostic tests are documented, including cultures and PCR results.
Comprehensive history of exposure and clinical findings related to the infection.
Patients with atypical presentations of keratitis or those with immunocompromised states.
Document any co-infections or underlying conditions that may complicate the infection.
Used when a comprehensive eye exam is performed to assess keratitis.
Document the findings of the eye examination and any diagnostic tests performed.
Ophthalmologists should ensure that all relevant symptoms and history are included.
Common symptoms include severe eye pain, redness, photophobia, blurred vision, and tearing. Patients may also experience a sensation of something in the eye.
Diagnosis is typically made through clinical examination, corneal scraping, and culture or PCR testing to identify the Acanthamoeba organism.
Treatment usually involves aggressive topical antimicrobial therapy, including biguanides and diamidines. In severe cases, surgical intervention may be necessary.
